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During 14 months of infection of a pig-tailed macaque, the acutely lethal simian immunodeficiency virus SIVsmmPBj14
(SIV-PBj14) evolved from the minimally pathogenic strain SIVsmm9. The virus isolated at 8 months (SIV-PBj8) exhibited
properties of both SIVsmm9 and SIV-PBj14, indicating that a phenotypic transition occurred between 6 and 10 months. To
assess the influence that this new composition of biologic properties might have on pathogenicity, three pig-tailed macaques
were inoculated intravenously with SIV-PBj8. Although no animals developed the severe acute disease syndrome typical of
SIV-PBj14, all had high levels of viremia and died of AIDS at 4, 10.5, and 32 months. Characterization of the SIV-PBj8-derived
quasispecies that evolved in these macaques showed that at 4 days after inoculation, viruses from all three animals exhibited
in vitro properties different from those of the inoculum. By 4 months, the initial phenotypic profiles had changed, with the
quasispecies in plasma from the animal (J90232) that died at this time most closely resembling SIV-PBj14, not SIV-PBj8.
Phylogenetic trees of the gp41/Nef region of viruses in 4-month plasma from J90232 revealed three distinct populations with
high bootstrap values: one group branched with SIVsmm9, one with SIV-PBj14, and one with SIV-PBj8 (ratio of clones, 5:9:5).
Nucleotide sequence analysis suggested that some members of the original SIV-PBj8 quasispecies may have been evolving
toward a SIV-PBj14-like genotype at the time macaque J90232 died. The use of SIV-PBj8, which was more pathogenic than
SIVsmm9, but less pathogenic than SIV-PBj14, may provide the optimal genetic background on which to identify the minimal,
multigenic determinants of the SIV-PBj14 phenotype. The results of our studies on SIV-PBj14 indicate that in some, but not
all, cases of primate lentivirus infection more pathogenic variants evolve, selectively proliferate, and more than likely
contribute to disease progression. © 1999 Academic Press
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lINTRODUCTION
Based on genetic analyses of human immunodefi-
iency virus (HIV) isolates obtained during the acute
hase of infection, it is generally accepted, although not
lways true, that one dominant genotype is transmitted,
rrespective of whether transmission is parenteral or
ucosal (Poss et al., 1995; Wolfs et al., 1992; Zhang et al.,
993; Zhu et al., 1993). Selection for transmission of a
imited number of genotypes also occurs in the SIV-
acaque model system (Trivedi et al., 1994; Amedee et
l., 1995). Phenotypically, most early HIV-1 viruses are
on syncytium inducing (NSI) and appear to be less
athogenic than isolates obtained as disease pro-
resses (Tersmette et al., 1989; Schuitemaker et al., 1992;
onnor and Ho, 1994; Koot et al., 1996). Many of these
ater isolates, unlike their predecessors, readily form
yncytia in MT2 cells, i.e., are syncytium inducing (SI), a
rait thought to contribute to increased pathogenicity.
his idea was suggested by the observation that dra-
atic decreases in numbers of CD41 lymphocytes in
eripheral blood mononuclear cells (PBMC) coincided
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Microbiology, University of Alabama
chool of Medicine, 845 19th Street South, BBRB 511, Birmingham, ALS5294. E-mail: pnf@uab.edu.
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166ith transition from a NSI to SI HIV phenotype (Connor et
l., 1993). However, since many HIV-infected patients
ith AIDS appear to harbor only NSI strains, it is possible
hat NSI strains also evolve to become more pathogenic
ver time without losing their NSI phenotype. It is impor-
ant, therefore, to identify viral determinants of pheno-
ypes that play a role in generating more virulent strains
o understand fully the pathogenesis of the primate len-
iviruses.
Evolution of less pathogenic to more pathogenic
trains, including some with a change from a NSI to a SI
henotype, has been described in the SIV-macaque
odel (Fultz et al., 1989; Rudensey et al., 1995; Whatmore
t al., 1995; Edmondson et al., 1998). The most extreme
xample of increased pathogenicity is the acutely lethal
train SIVsmmPBj14 (SIV-PBj14), which evolved from the
rototype SIVsmm9 during 14 months of infection of a
ig-tailed macaque, PBj (Fultz et al., 1989). Whereas
IVsmm9 induces an AIDS-like disease that progresses
lowly over several years, SIV-PBj14 induces acute dis-
ase and death in most macaques within 6 to 10 days
fter intravenous inoculation (Fultz and Zack, 1994). This
irulent in vivo phenotype has been shown to correlate
irectly with the ability of the virus to replicate in resting
acaque lymphocytes and to induce these cells to pro-
iferate in vitro (Fultz, 1991; Novembre et al., 1993;
chwiebert et al., 1997). Furthermore, the ability of SIV-
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167PATHOGENICITY AND EVOLUTION OF SIVsmmPBj8Bj14 to induce proliferation of, but not replicate in,
esting macaque PBMC and to cause acute disease and
eath is associated with the presence of a tyrosine
esidue at amino acid 17 (Y17) in Nef (Du et al., 1995;
aucier et al., 1998). All other naturally occurring SIV
trains encode an arginine (R17) in this position. How-
ver, although the nef mutation is necessary for the full
IV-PBj14 phenotype, other regions of the genome, such
s gag, are required (Novembre et al., 1993, 1996; Sauc-
er et al., 1998). This conclusion is supported by the
inding that a chimeric simian/human immunodeficiency
irus (SHIV) expressing the SIV-PBj14 nef gene exhibited
he in vitro properties of SIV-PBj14, but did not induce
igh viral burdens and acute disease and death in pig-
ailed macaques (Stephens et al., 1998). Also of rele-
ance, genetic determinants of a variant of SIVmne that
s more pathogenic than the parental virus and also
eplicates in resting macaque PBMC mapped to the gag
egion (Kimata et al., 1998).
Previously, we characterized a series of isolates, des-
gnated SIV-PBj3, -PBj6, -PBj8, -PBj10, etc., obtained se-
uentially from macaque PBj after infection with
IVsmm9 (Tao and Fultz, 1995). Analysis of genetic and
iologic properties of all sequential isolates revealed
hat a major transition in the in vitro phenotype occurred
etween 6 and 10 months after infection of macaque PBj.
ll viral quasispecies isolated from 10 months until death
xhibited the pathogenic properties of SIV-PBj14, while
hose isolated throughout the first 6 months of infection
id not. Although SIV-PBj14 had acquired a SI phenotype,
t also had an enhanced ability to replicate in pig-tailed
acaque monocyte-derived macrophages (Saucier et
l., 1998; Schwiebert and Fultz, unpublished data). The
IV-PBj8 quasispecies exhibited in vitro properties of
oth SIVsmm9 and SIV-PBj14 in that it induced prolifer-
tion of resting macaque PBMC only minimally, but was
s cytopathic for mangabey CD41 cells as SIV-PBj14
Tao and Fultz, 1995). Because these properties of SIV-
Bj14 segregated in SIV-PBj8, we believed that the use of
T
Viral Burdens and Disease Induction in Macaq
Macaque
Plasmaa TCID50
8d 14
J90232 1 3 104 3 3 104 50
J90306 3 3 103 1 3 105 46
J90311 3 3 103 3 3 104 24
a Infectious virus in plasma on day 4 for all three animals was 1 3
b SIV p27 Gag, pg/ml. All samples obtained on day 4 were negative
c Signs of disease during the first 4 weeks after virus inoculation.
d Day after intravenous inoculation.his isolate might optimize our chances to identify more srecisely other genomic determinants of SIV-PBj14’s var-
ous properties, the majority of which have been linked
nly to broad regions of the genome (Novembre et al.,
993; Saucier et al., 1998). In addition, we were inter-
sted in whether infection of pig-tailed macaques with
he SIV-PBj8 quasispecies would lead to the evolution of
ariants with properties similar to those of SIV-PBj14.
his report describes the in vivo pathogenicity of SIV-
Bj8 and the molecular and biologic evolution of vari-
nts during infection of macaques with this transitional
uasispecies.
RESULTS
linical disease course following inoculation
To determine the pathogenicity of SIV-PBj8, three pig-
ailed macaques were inoculated intravenously with the
1 stock of SIV-PBj8 (Table 1). With the exception of
iquid diarrhea of several days duration in one animal
J90311), none of the animals developed the acute dis-
ase syndrome characteristic of acute SIV-PBj14 infec-
ions. All three infected macaques had high levels of
lasma antigenemia and viremia during the first 2 weeks
fter infection (Table 1), but no interleukin (IL)-6 and no or
nly low levels of tumor necrosis factor (TNF)-a were
etected in serum samples (data not shown). Ultimately,
owever, all animals succumbed to AIDS: J90232 died at
months, J90311 at 10.5 months, and J90306 at 32
onths. The animal that died 4 months after infection
eveloped only a transient serum antibody response,
hereas the other two animals rapidly generated high
iters of SIV-specific antibodies that persisted throughout
nfection (Fig. 1A). During the last 28 months of its life,
90306 had extremely low percentages and numbers of
D41 T lymphocytes in peripheral blood (range, 2.2 to
.7%) with less than 80 such cells for the last 8 months
Fig. 1B). Although this animal had recurrent diarrhea and
evels of CD41 T cells indicative of AIDS, it continued to
ain weight until just before euthanasia due to progres-
oculated with the SIVsmmPBj8 Quasispecies
sma p27
genemiab
Clinical signsc
Death
(months)14
2450 Soft stool 4
5600 None 32
3920 Watery diarrhea 10.5
D50.ABLE 1
ues In
Pla
anti
8
50
00
50
103 TCI
.ive morbidity.
Bt
u
o
a
c
C
l
m
v
i
l
s
m
t
t
s
a
i
f
m
a
c
t
3
m
r
S
s
J
e
p
c
4
t
[
2
p
f
d
P
S
r
i
a
168 TAO AND FULTZiologic properties of viruses isolated after infection
Viruses recovered at different times from PBMC of the
hree SIV-PBj8-infected pig-tailed macaques were eval-
ated for those in vitro biologic properties characteristic
f SIV-PBj14 that segregated in SIV-PBj8: (i) replication in
FIG. 1. Seroconversion and loss of CD41 T cells after infection of
ig-tailed macaques with SIV-PBj8. (A) Serum antibody titers are de-
ined as the reciprocal of the highest serum dilution to yield an optical
ensity reading greater than the cutoff value. †Time of death. (B)
ercentages of CD41 cells in blood were determined by flow cytometry.
FIG. 2. Replication in resting pig-tailed macaque PBMC of viruses
IV-PBj8 and at the time of death (C). A and C reflect data obtained in
epresents a separate experiment with PBMC from a different donor. Be
n B and C were generated with the same virus stock. Control values ar
re shown.nd induction of proliferation of resting pig-tailed ma-
aque PBMC and (ii) cytopathic effects on mangabey
D41 lymphocytes. The recovered viruses included iso-
ates obtained from all three animals at 4 days and 4
onths after initial infection and at time of death. The
iral quasispecies recovered from J90311 at 4 days after
noculation replicated in resting macaque PBMC simi-
arly to those of SIVsmm9 and the inoculum SIV-PBj8 (not
hown), whereas the 4-day viruses from the other two
acaques replicated at levels intermediate between
hose of SIV-PBj14 and SIV-PBj8 (Fig. 2A). Viruses ob-
ained at 4 days from all three macaques exhibited the
ame levels of cytopathicity for mangabey CD41 T cells
s the SIV-PBj8 quasispecies (Fig. 3). At 4 months after
noculation, when macaque J90232 died, virus recovered
rom this animal not only replicated in resting pig-tailed
acaque PBMC as efficiently as SIV-PBj14 (Fig. 2B), but
lso had retained its cytopathicity for mangabey CD41 T
ells (Fig. 3). The quasispecies obtained from the other
wo macaques at 4 months and at their deaths (10.5 and
2 months after inoculation), however, replicated mini-
ally in resting macaque PBMC (Figs. 2B and 2C). These
esults suggested that a variant more pathogenic than
IV-PBj8 either had been amplified during the early
tages of infection or may have evolved in macaque
90232 during the 4-month period before its death.
Because the ability of SIV-PBj14 to cause acute dis-
ase and death is correlated with its ability to induce
roliferation of resting macaque PBMC, viral quasispe-
ies isolated from the three macaques’ PBMC at 4 days,
months, and death were incubated with resting pig-
ailed macaque PBMC for 7 days, and then the amount of
3H]thymidine incorporated into cellular DNA in the last
0 h was determined. The proliferative responses of all
red from macaques 4 days (A) and 4 months (B) after infection with
eriment using resting PBMC from the same donor animal, whereas B
macaque J90232 died 4 months after infection, the data for this animal
mples from uninfected cultures. Data from one of several experimentsrecove
the exp
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169PATHOGENICITY AND EVOLUTION OF SIVsmmPBj8iruses were substantially less than that induced by
IV-PBj14; most stimulation indices were within twofold
hat of SIVsmm9 (Fig. 4). Because the virus from J90232
t death had a stimulation index only 1.2 times greater
han that of SIVsmm9, the ability to induce proliferation of
esting macaque PBMC was the only in vitro property
hat this viral quasispecies did not share with SIV-PBj14.
n other experiments (not shown), stimulation indices for
ll recovered viruses were generally the same as those
or SIVsmm9.
FIG. 3. Cytopathicity for mangabey CD41 lymphocytes of viruses
ecovered from pig-tailed macaques after infection with SIV-PBj8.
angabey PBMC were stimulated with PHA before infection with
iruses recovered from all animals at 4 days after inoculation and from
90232 at death. In multiple experiments, infection with SIVsmm9 re-
ulted in no loss of mangabey CD41 lymphocytes; at all times the
ercentages of CD41 cells were essentially identical to those in the
ninfected control cultures.
FIG. 4. Induction of proliferation of resting pig-tailed macaque PBMC
fter exposure for 7 days to the indicated viruses or to concanavalin A
Con A). After the column showing stimulation by Con A, the set of two
r three columns with the same fill pattern reflect proliferative re-
ponses induced by viruses isolated from J90232 (s), J90306 (2), andm90311 (o), respectively. Bars reflect standard errors.hylogenetic analysis of viral quasispecies
The virus recovered from macaque J90232 at death
hared two of three biologic properties of SIV-PBj14 that
ere tested; therefore, it was of interest to assess the
iral genotypes that were present. Because virions in
lasma represent those proviruses being actively tran-
cribed, RNA was extracted from plasma virions and
mplified by RT–PCR. We initially analyzed a 511-base
air (bp) fragment at the 39 end of gp41env, which spans
he second exon of rev and the first 165 nucleotides (55
mino acids) of nef (fragment env-2/nef). Phylogenetic
nalysis of the nucleotide sequences of 19 amplicons
loned from the RT–PCR products revealed three distinct
hylogenetic subgroups (A, B, and C) each with high
ootstrap values (Fig. 5). The relative frequencies of the
mplicons in subgroups A, B, and C were 9:5:5, respec-
ively.
When the consensus nucleotide sequences of viruses
n the three J90232 subgroups were compared, not only
o SIVsmm9 and SIV-PBj14, but also to sequences of
iruses biologically cloned from sequential isolates SIV-
Bj6, -PBj8, and -PBj10, the same relationships of the
hree subgroups were maintained: subgroup A branched
ith SIV-PBj14, subgroup C branched with SIVsmm9, and
ubgroup B was more closely related to the consensus
equence of plasma virion RNA obtained from macaque
Bj at 8 months, that is, to viruses in the SIV-PBj8 inoc-
lum (Fig. 6). Consistent with their in vitro phenotypes,
nly those biologically cloned viruses that had the same
n vitro properties as SIV-PBj14 (SIV-PBj10-B2, -C1, and
C4) clustered with SIV-PBj14 (Tao and Fultz, 1995).
To assess whether comparable genetic evolution had
ccurred in the quasispecies circulating in macaques
90306 and J90311 during this same 4-month interval,
FIG. 5. Relationships of plasma virions from macaque J90232 at time
f death, 4 months after infection with SIV-PBj8, to SIVsmm9, SIV-PBj14,
nd the consensus sequence of the quasispecies in plasma from
acaque PBj at 8 months (SIV-PBj8-plcs). Unrooted phylogenetic tree
f the env-2/nef region; the larger numbers at the ends of branches are
lone designations for RT–PCR products. The three distinct subgroups
n J90232’s plasma are designated A, B, and C. Bootstrap values (small
umbers) greater than 50% for 100 replicate trees are shown.ultiple amplicons generated by RT–PCR of plasma viri-
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170 TAO AND FULTZns from these two animals were also sequenced. Phy-
ogenetic analysis of these sequences, the consensus
equences of J90232 subgroups A, B, and C, SIVsmm9,
IV-PBj14, and the consensus sequence of six amplicons
enerated from PBj’s plasma at 8 months showed that
he majority of the sequences from J90306, the animal
hat survived the longest, appeared to branch with
IVsmm9, although the bootstrap values were less than
0 (Fig. 7). The heterogeneity of the clones from J90311
ppeared to be greater than those from J90306, with
ore dispersion throughout the phylogenetic tree. Even
ith the inclusion of these additional sequences and
ooting the tree to SIVmac239, the relationships of the
90232 subgroups A, B, and C with SIVsmm9, PBj
-month plasma virions, and SIV-PBj14 were maintained,
lbeit with marginal bootstrap values.
enetic analysis of Env gp120-V1 and gp41, Nef,
nd the 39 LTR
The extent of diversity both within and between the
hree 4-month J90232 subgroups and between the quasi-
pecies of the three macaques were compared. The
iversity among env-2/nef amplicons within J90232 sub-
roups A, B, and C ranged from 0.22 to 2.18, 0.44 to 0.87,
nd 0.22 to 1.09%, respectively. When pairwise compar-
sons of all amplicons from all J90232 subgroups were
ade, the genetic distances ranged from 0.22 to 3.7%,
omparable to diversity within the J90306 and J90311
uasispecies (0.22 to 2.4 and 0.22 to 3.94%, respectively).
airwise genetic distances of all 50 env-2/nef amplicons
rom all three animals ranged from 0.22 to 3.94%.
As discussed above, arginine is encoded at residue 17
FIG. 6. Relationships in the env-2/nef region of the three J90232 viral
ubgroups to viruses biologically cloned from SIV-PBj6, -PBj8, and
PBj10 passage 1 viral stocks (Tao and Fultz, 1995). The consensus
equences of the clones from each subgroup (J90232-A, -B, and -C)
ere used to construct the unrooted tree. Bootstrap values greater than
0% for 100 replicate trees are indicated by numbers on the branches.n the nef genes of almost all SIV strains. A tyrosine mesidue at Nef amino acid 17, as in SIV-PBj14 and a
ariant recently isolated from a rhesus macaque infected
ith SIVmac239, is associated with the ability to replicate
n resting macaque PBMC (Du et al., 1996; Schwiebert et
l., 1997; Kirchhoff et al., 1999). Thus, the protein se-
uences in this region of Nef in viruses circulating in the
acaque recipients of SIV-PBj8 were evaluated. Of 50
mplicons from virions in plasma of the three macaques
t 4 months after infection, 49 of these encoded R17,
hereas one clone from J90232 encoded a cysteine
Table 2). This clone (No. 232-24) was in subgroup A,
hich branched with SIV-PBj14 in the phylogenetic anal-
sis (Fig. 5).
Other genetic characteristics of the SIV-PBj14 genome
ot shared by SIVsmm9 include the presence of a 15-bp
nsertion in the V1 region of env and a 22-bp duplication
n the LTR that generates a second NF-kB binding site
Dewhurst et al., 1990). These two regions in plasma
irions obtained from all three animals 4 months after
IV-PBj8 inoculation and at death from J90311 (10.5
onths) were amplified by RT–PCR and sequenced. As
n the SIV-PBj8 inoculum, no amplicons from any of the
lasma samples contained the 22-bp duplication in the
TR (Table 3). In the genomic region encoding Env V1, the
ajority of the amplicons (24 of 28) had no insertions
relative to SIVsmm9), whereas 4 amplicons had inser-
ions of either 6 or 9 bp. These results contrasted with
hose obtained with samples of 8-month plasma from
Bj; those viruses had insertions ranging from none to 57
p, and 1 amplicon had a deletion of 18 bp in Env V1.
DISCUSSION
SIV-PBj14 is unique among primate lentiviruses be-
ause of its extreme virulence, which is associated with
FIG. 7. Comparative evolution of SIV-PBj8 in the env-2/nef region
uring infection of macaques J90306, J90311, and J90232. Amplicons
ere generated by RT–PCR of plasma samples obtained 4 months after
nfection and are designated by the last three digits of the animal tatoo
ollowed by clone number. Only the consensus sequences of the three
ubgroups from J90232 were used. PBj8-plcs represents the consen-
us sequence for virions in plasma of macaque PBj at 8 months after
nfection with SIVsmm9. The phylogenetic tree was rooted to SIV-
ac239.
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171PATHOGENICITY AND EVOLUTION OF SIVsmmPBj8ts ability to replicate more efficiently than other SIVs and
IVs and to activate and induce lymphocytes to prolifer-
te. Identification of molecular determinants that confer
hese properties to the virus might provide important
nformation on the role of specific gene products in the
athogenesis of members of this retrovirus family. Al-
hough it has been demonstrated that the SIV-PBj14 in
itro and in vivo properties are multigenic, only a single
mino acid change in Nef, R17Y, has been identified
T
Genetic Analysis of Viruses Recovered fr
Macaque Monthsa Nef R17b LTRc 218
PBj 8 7/7 10 1
J90232 4e 29/30 f 10 —
J90306 4 10/10 6 —
J90311 4 10/10 5 —
J90311 10.5e 20/20 20 —
a Months after inoculation of macaques with SIVsmm9 (PBj) or SIV-P
b Number of amplicons encoding R17/total number sequenced.
c Number of amplicons of the LTR sequenced; none contained the 2
d Number of nucleotides deleted (218) or inserted in the V1 region o
equenced.
e Time of death.
f One cloned amplicon encoded a cysteine, R17C.
T
Summary of Biologic Properties Associated w
Virus Nef aa17a Replicationb
IV-PBj14 Y 1
IVsmm9 R 2
IV-PBj8 R 2
90232
4 days R 1
4 months R 1
90306
4 days R 1
4 months R 2
32 months R 2
90311
4 days R 2
4 months R 2
11 months R 2
GM/PBj14Nef Y 1
IVmac239YE Y 1
Bj6.6Y-R R 1
HIV-PBj14Nef Y 1
a Virus encodes a tyrosine (Y) or arginine (R) at residue 17 in Nef.
b Replication in resting pig-tailed macaque PBMC.
c Induction of proliferation of resting pig-tailed macaque PBMC.
d Loss of CD41 lymphocytes associated with replication in sooty ma
e Death within 2 weeks after intravenous inoculation of pig-tailed m
f nd, not done.nequivocally as an important requirement for the full
IV-PBj14 phenotype.
We previously showed that SIV-PBj8 exhibited in vitro
roperties of both the acutely lethal SIV-PBj14 and its
arental virus, SIVsmm9, indicating that the phenotype of
he virus isolated from macaque PBj at 8 months after
nfection with SIVsmm9 was transitional (Tao and Fultz,
995). Evidence that the majority of the individual viruses
n the SIV-PBj8 quasispecies had the genotype and com-
sma of SIVsmmPBj8-Infected Macaques
Env V1 nucleotide changesd
0 3 6 9 15 57 No.
5 1 3 — 1 1 12
6 — 1 1 — — 8
5 — — — — — 5
5 — — — — — 5
8 — 1 1 — — 10
0232, J90306, J90311).
uplication characteristic of SIV-PBj14.
No. reflects the total number of amplicons from each animal that was
Acutely Lethal Phenotype of SIVsmmPBj14
Proliferationc Mangabey CPEd Acute deathe
1 1 1
2 2 2
6 1 2
2 1 nd f
2 1 nd
2 1 nd
2 nd nd
2 nd nd
2 1 nd
2 nd nd
2 nd nd
nd nd 2
nd nd 6
2 nd 2
1 nd 2
y PBMC in vitro.
s.ABLE 2
om Pla
Bj8 (J9
2-bp d
f Env.ABLE 3
ith the
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172 TAO AND FULTZosite SIV-PBj8 phenotype includes the following: (i) all
1 biologic clones generated from SIV-PBj8 essentially
ad the phenotype of the quasispecies and (ii) of 28 TA
lones amplified from the inoculum by PCR, 27 clones
ncoded arginine and 1 clone encoded proline at amino
cid 17 in Nef (Tao and Fultz, 1995).
The results reported here show that uncloned SIV-PBj8
as less pathogenic than SIV-PBj14 but more pathogenic
han SIVsmm9, which rarely induces AIDS-like disease
ithin 2 years. Although none of the pig-tailed macaques
noculated intravenously with SIV-PBj8 developed rapid
evere disease and death, all three animals had high
evels of plasma viremia 8 to 14 days after infection,
omparable to levels routinely found in pig-tailed ma-
aques that die within 6 to 12 days after infection with
ither the SIV-PBj14 biologic clone bcl3 or molecular
lone 6.6 (Schwiebert and Fultz, 1994; Novembre et al.,
994). In contrast to SIV-PBj14 infection, none of the
IV-PBj8 recipients had measurable levels of plasma IL-6
r TNF-a. These findings indicate that (i) high viral bur-
ens per se are not directly responsible for the acutely
ethal disease and (ii) high levels of plasma IL-6 and
NF-a are not necessarily a consequence of high viral
urdens.
Based on previous studies, not only with SIV-PBj14-
elated viruses, but also other SIV strains (Whatmore et
l., 1995; Schwiebert et al., 1997; Edmondson et al., 1998),
e postulated that it was possible that a member of the
IV-PBj8 quasispecies with a replication advantage
ight be amplified preferentially early after infection;
herefore, viruses recovered from the three macaques on
ay 4 after inoculation were characterized. Of those
solates obtained from the SIV-PBj8 recipients, only the
irus recovered from J90311 exhibited in vitro phenotypic
haracteristics comparable to those of the SIV-PBj8 in-
culum. That the viruses isolated on day 4 from the other
wo SIV-PBj8 recipients were able to replicate in resting
acaque PBMC tends to support the idea that this phe-
otype may provide some advantage to a virus. Because
acaque J90232 developed only a transient, low-level
ntibody response and progressed rapidly to AIDS, it is
ossible that this failure of the immune system allowed
ore fit variants to outgrow others. The virus isolated
rom J90232 at death (4 months after inoculation) repli-
ated in resting pig-tailed macaque PBMC as efficiently
s SIV-PBj14, was cytopathic for mangabey CD41 T cells,
ut was unable to induce proliferation of pig-tailed ma-
aque PBMC. Although the pathogenicity of this day-4
irus for pig-tailed macaques was not evaluated, it is
nlikely that it would have induced acute disease be-
ause of its nef genotype; all PCR-amplified and se-
uenced fragments encoded R17. In support of this con-
lusion, a virus in which Nef Y17 of the SIV-PBj14-6.6
olecular clone was mutated to arginine (Y17R) had theame in vitro phenotype as J90232’s 4-day and 4-month airuses, but it did not induce acute disease and death
Saucier et al., 1998).
The quasispecies obtained at death from the rapid
rogressor, J90232, most closely resembled SIV-PBj14 in
henotype and genotype. Phylogenetic analyses of mul-
iple PCR-amplified, cloned fragments from the env-2/nef
egion of plasma virions revealed three distinct sub-
roups present in approximately equal numbers. Be-
ause macaque J90232 had a high viral burden at death,
he 9:5:5 ratio of clones in each of the three subgroups is
ikely to be a true reflection of their relative proportions.
hat the most prevalent subgroup always branched in
hylogenetic trees with SIV-PBj14 and SIV-PBj10 biolog-
cal clones that exhibited the SIV-PBj14 phenotype might
ndicate that more pathogenic variants were evolving.
lthough these results do not prove that the J90232
-month virus is more pathogenic than SIV-PBj8, they are
ighly suggestive that this is true.
Compared to SIVsmm9 and SIV-PBj8, the genetic anal-
sis of viruses isolated from the three animals at 4
onths after infection revealed no or only minimal
hanges in the LTR, Env V1, or overlapping gp41/Nef
egions. Of 50 amplicons obtained by RT–PCR amplifica-
ion of plasma virion RNA at 4 months after infection, 49
mplicons encoded R17 and 1 from J90232, which
ranched with SIV-PBj14, encoded cysteine (R17C). The
odon for cysteine (TGC) is a natural intermediate in the
onversion of arginine (CGC) to tyrosine (TAC), indicating
hat mutation from arginine (CGC) to cysteine (TGC) to
yrosine (TAC) may have been a pathway in the evolution
f SIV-PBj14. This pathway is consistent with our earlier
tudy showing that loss of the SIV-PBj14 phenotype dur-
ng long-term infection of pig-tailed macaques was as-
ociated with stepwise mutations in Nef from Y17 (TAC)
o H17 (CAC) or C17 (TGC) to R17 (CGC) (Schwiebert et
l., 1997). Thus, it is possible that a proportion of the
uasispecies in macaque J90232 was evolving in a man-
er similar to that of SIVsmm9 during generation of
IV-PBj14. Whether the R17C change has any impact on
iral phenotype can only be tested using isogenic mo-
ecularly cloned viruses.
Although other investigators have generated and eval-
ated chimeric viruses containing various portions of the
IV-PBj14 genome, with one exception these studies did
ot utilize genomic segments derived from directly re-
ated SIVs. In one study the only region of the parental
IVsmm9 used to generate chimeras was the env gene;
he results indicated that the gp120 portion of env was
ot required for the SIV-PBj14 phenotype (Novembre et
l., 1994). SIV-PBj14 chimeric viruses containing regions
f the genome other than env and nef have employed
nrelated viruses, such as SIVsmmH4 and SIVagm3mc
Novembre et al., 1993; Wagener et al., 1998). In addition,
SIV/HIV (SHIV) chimera composed of the 39 half of
IVmac239, the tat, rev, vpu, and env genes of HIV-1LAI(IIIB),
nd the nef gene of SIV-PBj14 was made. This SHIV had
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173PATHOGENICITY AND EVOLUTION OF SIVsmmPBj8he in vitro phenotype of SIV-PBj14, but replicated poorly
n pig-tailed macaques with no accompanying disease
Stephens et al., 1998), and was the first SIV-PBj14-re-
ated example where the ability to induce proliferation of
esting lymphocytes does not correlate with an acutely
ethal disease. Although the full complement of SIV-
Bj14’s in vitro properties was not tested, the recombi-
ant SIVs and SHIV replicated in and the SHIV chimera
nduced proliferation of resting pig-tailed macaque
BMC. However, none of these viruses induced acute
isease and death.
Thus, to date all of the studies to identify molecular
eterminants of the SIV-PBj14 in vivo phenotype indicate,
ot surprisingly, that it is a multigenic trait. When the
roperties of all recombinant viruses containing parts of
he SIV-PBj14 genome or Nef Y17 are compared (Table
), several conclusions can be made: (i) Nef Y17 is not
equired for replication in resting pig-tailed macaque
BMC; (ii) Nef Y17 is not required to elicit cytopathic
ffects for mangabey CD41 lymphocytes; (iii) Nef Y17 is
ot the sole determinant of acutely lethal disease; (iv) the
bility to replicate in and induce proliferation is not re-
uired for cytopathicity for mangabey CD41 lymphocytes;
nd (v) the ability to replicate in and induce proliferation
s not sufficient to cause acute disease and death. It
hould also be noted that the ability of both the
IVmne027 variant and SIVmac239YENef to replicate in
esting macaque PBMC is dependent on macrophages
Du et al., 1995; Kimata et al., 1998). This requirement,
owever, does not apply to SIV-PBj14 (Schwiebert and
ultz, 1994; Saucier et al., 1998). The enhanced pathoge-
icity of SIV-PBj8 and its direct relationship to both
IVsmm9 and SIV-PBj14 should provide a more relevant
ackground for identifying various regions of the genome
hat together confer on SIV-PBj14 its acutely lethal phe-
otype. An infectious SIV-PBj8 molecular clone has been
onstructed for such studies.
MATERIALS AND METHODS
iruses and cells
First passage (P1) virus stocks of SIV-PBj8 and SIV-
Bj14 were generated on phytohemaggluttinin P (PHA)-
timulated normal human PBMC by a single passage of
he primary isolates. The stocks were titered by end-
oint 10-fold serial dilutions and infection of normal pig-
ailed macaque PBMC in duplicate to determine the 50%
issue culture infectious dose (TCID50). To recover virus
t different times after inoculation, PBMC from infected
acaques were cocultivated with human PBMC, and
ulture supernatants were monitored for particulate re-
erse transcriptase (RT) activity (Schwiebert and Fultz,
994). PBMC were obtained from normal pig-tailed ma-
aques, sooty mangabeys, or humans by centrifugation
f heparinized whole blood through Ficoll–sodium dia-rizoate gradients (LSM; Organon Teknika). Unless oth- crwise specified, all cultures of human or macaque
BMC were maintained in RPMI 1640 medium supple-
ented with glutamine, antibiotics, 10% fetal bovine se-
um (FBS), and recombinant human IL-2 (8 U/ml).
nimals
Three clinically normal, juvenile pig-tailed macaques,
eronegative for SIV, type D simian retroviruses, and
imian T-cell lymphotropic virus, were used in this study.
he animals were housed at the University of Alabama at
irmingham in accordance with institutional and Animal
elfare Act guidelines. After intravenous inoculation of 1
l of uncloned first passage SIV-PBj8 containing 1.5 3
04 TCID50, blood samples were collected at regular
ntervals for hematologic, serologic, and virologic analy-
es. The macaques were observed daily, and physical
xaminations were performed at the time of each blood
ollection. Uninfected adult pig-tailed macaques and
ooty mangabeys were used as donors of normal PBMC.
nimals were anesthetized with ketamine hydrochloride
10 mg/kg) before all manipulations.
irus load and antibody titers
Aliquots of plasma (100 ml) or 10-fold serial dilutions of
lasma samples were added to duplicate wells of 24-
ell microtiter plates containing 1 3 106 PHA-stimulated
ormal human PBMC in 2 ml complete medium. Cultures
ere monitored periodically for RT activity, as described
bove. The TCID50 was calculated from the number of
ositive wells at each dilution using the method of Reed
nd Muench. An SIV p27 Antigen ELISA kit (Cellular
roducts) was used to determine concentrations of SIV
27 Gag in plasma samples. Serum antibody titers to SIV
ere determined using a highly cross-reactive HIV-2 EIA
it (Sanofi Pasteur Diagnostics, Seattle, WA).
n vitro biologic properties of recovered viruses
Experiments to evaluate replication of recovered vi-
uses in resting macaque PBMC and induction of prolif-
ration were performed as described previously (Tao
nd Fultz, 1995). As a measure of virus replication, ali-
uots of cell-free supernatants were removed from cul-
ures every 5 days and assayed for RT activity. To deter-
ine percentages of CD41 and CD81 T cells in primary
BMC from sooty mangabeys, on various days after
nfection, aliquots of 2 3 105 cells were removed,
ashed, and incubated with equal amounts of phyco-
rythrin (PE)-labeled leu3a (CD4) and fluorescein isothio-
yanate (FITC)-labeled leu2a (CD8) (Becton–Dickinson).
CR or RT–PCR amplification, cloning,
nd sequencing
Protocols and reagents for PCR amplification, ampli-
on purification, cloning, and nucleotide sequencing of
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174 TAO AND FULTZroviral DNA or cDNA generated from plasma virion RNA
ere performed as described (Tao and Fultz, 1995). Be-
ore RT–PCR amplification, virions were concentrated by
ltracentrifugation of plasma from infected macaques.
iral RNA was extracted from the pellet using a mi-
roscale total RNA separation kit (Clontech Laboratories,
alo Alto, CA). cDNA was synthesized from the RNA
emplate using the oligonucleotide primer PBj-LTR-D,
9-AGAAGAGTTTGGTAGTCAGTCAGG-39, with a first-
trand cDNA synthesis kit (Clontech Laboratories). As
emplate, genomic DNA or cDNA was used for PCR
mplification of a 511-bp fragment at the 39 end of the
p41env gene. The oligonucleotide primers were PBj-env-
II, 59-GACAGGGTTATAGGCCAGTGTTC-39, and PBj-env-
V, 59-ATTGACCCTCACAATATTTCTGAGG-39. The nucleo-
ide primers used to PCR amplify the U3 enhancer region
n the LTR and the V1 region of env have been described
Tao and Fultz, 1995). Relationships of nucleotide se-
uences were analyzed by the neighbor-joining method,
hylogenetic trees were constructed and evaluated sta-
istically with 100 bootstrap replicates, and genetic dis-
ances were determined by pairwise comparisons using
he two-parameter method of Kimura (PHYLIP, Version
.75C, program).
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